Atlas Venture Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
18

- Investments
-
781
- Portfolio
-
51
- Exits
-
406

Atlas Venture General Information
Company Description
Founded in 1980, Atlas Venture is a leading biotech venture capital firm based in Cambridge, Massachusetts. The firm has been building breakthrough biotech startups for over 30 years. The firm has exceptional scientists and entrepreneurs to translate high-impact science into medicines for patients. The firm's seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.
Business Details
Website
www.atlasventure.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 300 Technology Square
- 8th Floor
- Cambridge, MA 02139
- United States
Atlas Venture Investments & Acquisitions (781)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
nChroma Bio | 05-Dec-2024 | Early Stage VC | Biotechnology | Generating Revenue | ||
Trace Neuroscience | 12-Nov-2024 | Laboratory Services (Healthcare) | Generating Revenue | |||
Judo Bio | 07-Oct-2024 | Drug Discovery | Pre-Clinical Trials | |||
Be Biopharma | 01-Oct-2024 | Drug Discovery | Generating Revenue | |||
Kailera Therapeutics | 01-Oct-2024 | Drug Discovery | Clinical Trials - Phase 3 | |||
Triveni Bio | 19-Sep-2024 | Drug Discovery | Pre-Clinical Trials | |||
GRO Biosciences | 19-Jul-2024 | Biotechnology | Generating Revenue | |||
Scorpion Therapeutics | 16-Jul-2024 | Drug Discovery | Generating Revenue | |||
Pheon Therapeutics | 21-May-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
Korro Bio | 22-Apr-2024 | PIPE | Drug Discovery | Generating Revenue/Not Profitable |
Atlas Venture Exits (406)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Sionna Therapeutics | 07-Feb-2025 | IPO | |
Disc Medicine | 23-Jan-2025 | ||
Nvelop Therapeutics | 11-Dec-2024 | ||
Chroma Medicine | 04-Dec-2024 | ||
Navitor Pharmaceuticals | 25-Oct-2024 | ||
CardFlight | 15-Oct-2024 | ||
AVROBIO | 20-Jun-2024 | ||
Disc Medicine | 14-Jun-2024 | ||
JenaValve Technology | 08-Apr-2024 | PE Growth/Expansion | |
Aiolos Bio | 14-Feb-2024 | Merger/Acquisition |
Atlas Venture Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Atlas Venture Investments by Industry, Year, and Region
Atlas Venture Co-Investors (157)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
RA Capital Management | 12 |
![]() |
![]() |
||
Surveyor Capital |
![]() |
![]() |
|||
GV |
![]() |
![]() |
|||
Alexandria Venture Investments |
![]() |
![]() |
|||
OrbiMed |
![]() |
![]() |
Atlas Venture FAQs
-
What is Atlas Venture?
Founded in 1980, Atlas Venture is a leading biotech venture capital firm based in Cambridge, Massachusetts.
-
When was Atlas Venture founded?
Atlas Venture was founded in 1980.
-
Where is Atlas Venture headquartered?
Atlas Venture is headquartered in Cambridge, MA.
-
What is Atlas Venture's total asset value?
Atlas Venture has around
in total assets under management. -
How many investments has Atlas Venture made?
Atlas Venture has made 781 investments.
-
What has Atlas Venture invested in?
Atlas Venture has made numerous investments in companies like nChroma Bio, Trace Neuroscience, and Judo Bio within the Biotechnology, Laboratory Services (Healthcare), and Drug Discovery industries.
-
What has Atlas Venture invested in recently?
Atlas Venture's latest investment was on 05-Dec-2024 in nChroma Bio, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »